uniQure (QURE) Cash & Equivalents (2015 - 2026)
uniQure (QURE) posted Cash & Equivalents of $413.0 million for Q2 2026, up 195.03% on a QoQ basis from $140.0 million in Q1 2026, and up 62.75% year-over-year from $253.8 million in Q2 2025.
Powered by 
Analysis
uniQure (QURE) Cash & Equivalents (2015 - 2026) Analysis & Trends
uniQure has reported Cash & Equivalents for 12 years, with the latest figure at $413.0 million in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 62.75% year-over-year to $413.0 million in Q2 2026; TTM through Jun 2026 was $413.0 million, a 62.75% increase from a year earlier, with the FY2025 full-year figure at $80.2 million, down 49.51% from the prior year.
- Cash & Equivalents was $413.0 million for Q2 2026 at uniQure, up from $140.0 million in the prior quarter.
- The five-year high for Cash & Equivalents was $597.1 million in Q3 2025, with the low at $80.2 million in Q4 2025.
- Average Cash & Equivalents over 5 years is $304.2 million, with a median of $247.3 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Cash & Equivalents slumped 70.69% in 2023, then soared 137.28% in 2025.
- Over 5 years, Cash & Equivalents stood at $228.0 million in 2022, then increased by 5.85% to $241.4 million in 2023, then plunged by 34.15% to $158.9 million in 2024, then plunged by 49.51% to $80.2 million in 2025, then surged by 414.74% to $413.0 million in 2026.
- The last three Cash & Equivalents figures came in at $413.0 million (Q2 2026), $140.0 million (Q1 2026), and $80.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 6.14 Bn |
| 10 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn | 413.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 413.03 Mn |
| Mar 31, 2026 | 139.99 Mn |
| Dec 31, 2025 | 80.24 Mn |
| Sep 30, 2025 | 597.06 Mn |
| Jun 30, 2025 | 253.78 Mn |
| Mar 31, 2025 | 217.23 Mn |
| Dec 31, 2024 | 158.93 Mn |
| Sep 30, 2024 | 251.63 Mn |
| Jun 30, 2024 | 287.88 Mn |
| Mar 31, 2024 | 243.06 Mn |
| Dec 31, 2023 | 241.36 Mn |
| Sep 30, 2023 | 229.48 Mn |
| Jun 30, 2023 | 513.60 Mn |
| Mar 31, 2023 | 153.85 Mn |
| Dec 31, 2022 | 228.01 Mn |
| Sep 30, 2022 | 440.31 Mn |
| Jun 30, 2022 | 500.52 Mn |
| Mar 31, 2022 | 524.89 Mn |
| Dec 31, 2021 | 556.26 Mn |
| Sep 30, 2021 | 578.46 Mn |
API Access
uniQure Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=QURE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "QURE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=QURE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();